{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:25:37Z","timestamp":1793618737786,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40257-021-00628-1","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T06:03:43Z","timestamp":1635314623000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey"],"prefix":"10.1007","volume":"23","author":[{"given":"Jerry","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Beissert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Cook-Bolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Chavda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Lain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dr\u00e9no","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"issue":"1 Suppl","key":"628_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"H Gollnick","year":"2003","unstructured":"Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37.","journal-title":"J Am Acad Dermatol"},{"issue":"5 Suppl","key":"628_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","volume":"60","author":"D Thiboutot","year":"2009","unstructured":"Thiboutot D, Gollnick H, Bettoli V, Dr\u00e9no B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1-50.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"628_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1046\/j.1365-2230.2001.00839.x","volume":"26","author":"AR Martin","year":"2001","unstructured":"Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne\u2014assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26(5):380\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"628_CR4","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","volume":"134","author":"RJ Hay","year":"2014","unstructured":"Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Investig Dermatol. 2014;134(6):1527\u201334.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"628_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2230.1994.tb01200.x","volume":"19","author":"AM Layton","year":"1994","unstructured":"Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19(4):303\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"628_CR6","first-page":"97","volume":"16","author":"J Tan","year":"2017","unstructured":"Tan J, Kang S, Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA. J Drugs Dermatol. 2017;16(2):97\u2013102.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"628_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1468-3083.2001.00357.x","volume":"15","author":"F Poli","year":"2001","unstructured":"Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol. 2001;15(6):541\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"628_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/00015550252948121","volume":"82","author":"CK Yeung","year":"2002","unstructured":"Yeung CK, Teo LH, Xiang LH, Chan HH. A community-based epidemiological study of acne vulgaris in Hong Kong adolescents. Acta Derm Venereol. 2002;82(2):104\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"628_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1046\/j.1365-2133.1997.18131897.x","volume":"137","author":"JA Cotterill","year":"1997","unstructured":"Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 1997;137(2):246\u201350.","journal-title":"Br J Dermatol"},{"issue":"9","key":"628_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1346-8138.2005.tb00829.x","volume":"32","author":"E Ilgen","year":"2005","unstructured":"Ilgen E, Derya A. There is no correlation between acne severity and AQOLS\/DLQI scores. J Dermatol. 2005;32(9):705\u201310.","journal-title":"J Dermatol"},{"issue":"1","key":"628_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00128071-200001010-00001","volume":"1","author":"GJ Goodman","year":"2000","unstructured":"Goodman GJ. Management of post-acne scarring. What are the options for treatment? Am J Clin Dermatol. 2000;1(1):3\u201317.","journal-title":"Am J Clin Dermatol"},{"key":"628_CR12","unstructured":"Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. US Food & Drug Administration. 2009. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims. Accessed 03 Mar 2021."},{"issue":"3","key":"628_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bjd.12149","volume":"168","author":"K Bhate","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474\u201385.","journal-title":"Br J Dermatol"},{"issue":"6","key":"628_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2310\/7750.2007.00037","volume":"11","author":"JK Tan","year":"2007","unstructured":"Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, et al. Development and validation of a comprehensive acne severity scale. J Cutan Med Surg. 2007;11(6):211\u20136.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"628_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s13555-016-0098-5","volume":"6","author":"A Layton","year":"2016","unstructured":"Layton A, Dr\u00e9no B, Finlay AY, Thiboutot D, Kang S, Lozada VT, et al. New patient-oriented tools for assessing atrophic acne scarring. Dermatol Ther (Heidelb). 2016;6(2):219\u201333.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"3","key":"628_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"628_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/00048679809062719","volume":"32","author":"P Oosthuizen","year":"1998","unstructured":"Oosthuizen P, Lambert T, Castle DJ. Dysmorphic concern: prevalence and associations with clinical variables. Aust N Z J Psychiatry. 1998;32(1):129\u201332.","journal-title":"Aust N Z J Psychiatry"},{"key":"628_CR18","unstructured":"Tan JCR, Leclerc M, York J, Dr\u00e9no B. The burden of acne scars: a qualitative study on patient experience. In: EADV 29th Congress; New Frontiers in Dermatology and Venereology P0052; 2020."},{"issue":"5","key":"628_CR19","first-page":"997","volume":"159","author":"MKA Basra","year":"2008","unstructured":"Basra MKA, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994\u20132007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159(5):997\u20131035.","journal-title":"Br J Dermatol"},{"issue":"3","key":"628_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/0974-2077.167272","volume":"8","author":"SY Chuah","year":"2015","unstructured":"Chuah SY, Goh CL. The impact of post-acne scars on the quality of life among young adults in Singapore. J Cutan Aesthet Surg. 2015;8(3):153\u20138.","journal-title":"J Cutan Aesthet Surg"},{"issue":"6","key":"628_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4103\/0378-6323.86481","volume":"77","author":"L Chularojanamontri","year":"2011","unstructured":"Chularojanamontri L, Sethabutra P, Kulthanan K, Manapajon A. Dermatology life quality index in Thai patients with systemic sclerosis: a cross-sectional study. Indian J Dermatol Venereol Leprol. 2011;77(6):683\u20137.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"8","key":"628_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1177\/1359105309342470","volume":"14","author":"J Hassan","year":"2009","unstructured":"Hassan J, Grogan S, Clark-Carter D, Richards H, Yates VM. The individual health burden of acne: appearance-related distress in male and female adolescents and adults with back, chest and facial acne. J Health Psychol. 2009;14(8):1105\u201318.","journal-title":"J Health Psychol"},{"issue":"2","key":"628_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1365-2133.1999.02662.x","volume":"140","author":"SC Kellett","year":"1999","unstructured":"Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol. 1999;140(2):273\u201382.","journal-title":"Br J Dermatol"},{"issue":"7320","key":"628_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/bmj.323.7320.1015","volume":"323","author":"KA Phillips","year":"2001","unstructured":"Phillips KA, Castle DJ. Body dysmorphic disorder in men. BMJ (Clin Res Ed). 2001;323(7320):1015\u20136.","journal-title":"BMJ (Clin. Res. Ed)."},{"issue":"3","key":"628_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/0890334419848734","volume":"35","author":"HL Ball","year":"2019","unstructured":"Ball HL. Conducting online surveys. J Hum Lact. 2019;35(3):413\u20137.","journal-title":"J Hum Lact"},{"issue":"2","key":"628_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/jdv.13945","volume":"31","author":"CL Thomas","year":"2017","unstructured":"Thomas CL, Kim B, Lam J, Richards S, See A, Kalouche S, et al. Objective severity does not capture the impact of rosacea, acne scarring and photoaging in patients seeking laser therapy. J Eur Acad Dermatol Venereol. 2017;31(2):361\u20136.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00628-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00628-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00628-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T01:00:35Z","timestamp":1642726835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00628-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00628-1","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"7 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by Galderma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"JT has acted as an advisor, consultant, investigator, and\/or speaker and received grants\/honoraria from Almirall, Boots Walgreens, Bausch, Cipher, Galderma, L'Oreal, and Sun. SB has acted as an advisor for AbbVie Deutschland GmbH & Co, Actelion Pharmaceuticals GmbH, Almirall-Hermal GmbH, Amgen GmbH, Celgene GmbH, Galderma Laboratorium GmbH, Janssen-Cilag GmbH, Leo Pharma GmbH, Lilly Deutschland GmbH, Menlo Therapeutics, MSD Sharp & Dohme GmbH, Novartis Pharma GmbH, Pfizer Pharma GmbH, Sanofi-Aventis Deutschland GmbH, and UCB Pharma GmbH, and has received speaker honorarium from Novartis Pharma GmbH, AbbVie, MSD, Pfizer, Janssen-Cilag, La\u00a0Roche-Posay, Actelion, GSK, BMS, Celgene, Almirall, and Hexal-Sandoz. FCB has acted as an advisor, consultant, investigator, and\/or speaker and received grants\/honoraria from Almirall, Cassiopea, Foamix Pharmaceuticals, Galderma, and Ortho Dermatologics. RC is an employee of Galderma. JH has acted as an advisor, consultant, and\/or speaker and received honoraria from Almirall, BioPharmX, Cassiopeia, Cutanea, Cutera, Dermira, EPI Health, Galderma, La Roche-Posay, Ortho Dermatologics, Sol Gel, Sun, and Vyne. AH has acted as an advisor, consultant, investigator, and\/or speaker and received grants\/honoraria from Allergan, Cassiopea, Galderma, GSK, La Roche-Posay, Novan, Ortho Dermatologics, Regeneron Sanofi, and Vyne. EL has acted as an advisor, consultant, investigator, and\/or speaker and received grants\/honoraria from AbbVie, Aclaris Therapeutics Inc., Allergan Inc., Almirall, AstraZeneca, Athenix, Biopelle Inc., BioPharmX, Biorasi LLC, BMS, Brickell Biotech Inc., Cassiopea S.p.A., Celgene, Cellceutix, ChemoCentryx, Cutanea Life Sciences, Demira, Dow Pharmaceutical Sciences Inc., Dr Reddy's Laboratory, Eli Lilly and Company, Gage Development Company LLC, Galderma Laboratories L.P., Galderma USA, Hovione, Kadmon Corporation LLC, La Roche-Posay, LEO Pharma, Medimmune, Menlo Therapeutics, Moleculin LLC, Neothetics, Nielsen Holdings N.V,, Novartis, Ortho Dermatologics, Pfizer Inc., Promius Pharma LLC, Sebacia Inc., Sienna Labs Inc., SkinCeuticals LLC, Sol-Gel Technologies, UCB, and Valeant Pharmaceuticals North America LLC. AL has acted as an advisor, consultant, investigator, and\/or speaker and received grants\/honoraria from Galderma, GSK, L\u2019Oreal, La Roche-Posay, Origimm, Leo Pharma, and Proctor & Gamble. MR has acted as an advisor and\/or speaker and received honoraria from Eucerin, Galderma, Johnson & Johnson, and Leo Pharma. JW has acted as an advisor, consultant, investigator, and\/or speaker and received grants\/honoraria from Almirall, Bausch, Cassiopea, Cutera, EPI Health, Foamix, Galderma, and Ortho Dermatologics. BD has acted as an advisor, consultant, and\/or speaker and received honoraria from BMS, Galderma, La Roche-Posay, Merck Serono, Pierre Fabre, and Sanofi.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"A copy of the study questionnaire is available on request. Individual data cannot be shared for privacy reasons.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"JT, BD, RC: made substantial contributions to the conception or design of the work and the\u00a0analysis or interpretation of data; drafted the work and revised it critically for important intellectual content; approved the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. SB, FC-B, JH, AH, EL, AL, MR, JW: made substantial contributions to the analysis and interpretation of data; revised the work critically for important intellectual content; approved the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The Kantar Independent Review Board\/Ethics Committee conducted\u00a0a detailed review of the study and reached a favorable opinion on the 30th of September 2021 (retrospective approval).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided informed consent prior to participation.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}